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Dear Editor, 
Sugammadex is a modiﬁ ed gamma cyclodextrin 1-3. Cyclodextrins 
are water soluble cyclic oligosaccharides with a lipophilic 
core. Sugammadex has quickly found a place in clinical use 
for selective antagonism of neuromuscular blockade with ro-
curonium 1-3. Sugammadex quickly encapsulates steroidal neu-
romuscular blockers, increasing the amount of encapsulated 
steroidal neuromuscular blockers in plasma and separating the 
blockers from the nicotinic acetylcholine receptors 1-3.
Apart from its use with steroidal neuromuscular block-
ers, it is known that sugammadex interacts with over 40 
lipophilic, steroidal and non-steroidal drugs. These drugs 
include: propofol, thiopental, fentanyl, remifentanil, van-
comycin, gentamicin, salbutamol, aminophylline, atropine, 
digoxin, ephedrine, phentolamine, verapamil, cortisone and 
hydrocortisone 4.
Previous research shows that, apart from steroidal 
muscle relaxants, sugammadex forms precipitates with 
protamine 5.
There is no clinical data on whether sugammadex forms 
precipitates with other drugs, commonly used in clinical prac-
tice. The hypothesis of this study is to investigate whether 
the chemical and physical properties of sugammadex would 
contribute to a precipitation reaction with drugs commonly 
used in clinical practice.
With this aim, simply 0.1 mL containing 100 mg.mL-1 sug-
ammadex was mixed on a glass slide with the same volume 
of a drug and the presence or absence of precipitation was 
determined under the microscope. The drugs investigated 
are all commonly used in clinical anesthesia practice. They 
include: adrenalin (1 mg.mL-1), atropine (1 mg.mL-1), amio-
darone (50 mg.mL-1), aminophylline (24 mg.mL-1), ornidazole 
(500 mg.3 mL-1), bupivacaine (5 mg.mL-1), cefazolin sodium 
(250 mg.mL-1), dexmedetomine (100 μg.mL-1), dobutamine 
(12.5 mg.mL-1), dopamine (8 mg.mL-1), ephedrine (0.05 g.mL-1), 
esmolol (10 mg.mL-1), esomeprazole (40 mg.mL-1), etomidate 
(2 mg.mL-1), fentanyl (50 μg.mL-1), ﬂ umazenil (0.1 mg.mL-1), 
furosemide (10 mg.mL-1), gentamicin (40 mg.mL-1), glyceryl 
trinitrate (5 mg.mL-1), heparin (1,000 IU.mL-1), hydrocor-
tisone (250 mg.mL-1), crystallized insulin (100 IU.mL-1), 
Calcium (Calcium Gluconate Monohydrate 225 mg.10 mL-1 
+ Calcium levulinate dihitrate 572 mg.10 mL-1), ketamine 
(50 mg.mL-1), levobupivacaine (7.5 mg.mL-1), magnesium 
sulphate (1.2 mEq.mL-1), metamizol sodium (0.5 g.mL-1), 
methylergobasin maleate (0.2 mg.mL-1), metoclopramide 
(5 mg.mL-1), metoprolol (1 mg.mL-1), morphine (0.01 g.mL-1), 
midazolam (5 mg.mL-1), n-acetylcysteine (100 mg.mL-1),
naloxone (0.4 mg.mL-1), neostigmine (0.5 mg.mL-1), nitroprus-
side (12 mg.mL-1), noradrenaline (1 mg.mL-1), oxytocin (5 IU.mL-1), 
paracetamol (10 mg.mL-1), thiopental sodium (25 mg.mL-1), 
pethidine (50 mg.mL-1), pheniramine (22.75 mg.mL-1), 
phenytoin (50 mg.mL-1), piracetam (1 g.5 mL-1), prednisolone 
(25 mg), prilocaine (20 mg.mL-1), propafenone (3.5 mg.mL-1), 
pro tamine hydrochloride (1,000 IU.mL-1), potassium (1 mEq.mL-1), 
remifentanil (5 mg.mL-1), cefuroxime axetil (125 mg.mL-1), 
sulbactam-ampicillin (200 mg.mL-1), succinylcholine 
(20 mg.mL-1), tenoxicam (10 mg.mL-1), theophylline (24 mg.
mL-1), tramadol (50 mg.mL-1), and vitamin K (10 mg.mL-1). 
A scale of 0-4 was used to evaluate the test, with 0 being 
no precipitation and 4+ being strong precipitation.
Within seconds, sugammadex (100 mg.mL-1) scored 4+ pre-
cipitation with amidarone (50 mg.mL-1), dobutamine (12.5 mg.
mL-1) and protamine hydrochloride (1,000 IU.mL-1).
There are reports on the incompatibility and precipitation 
of anesthetic drugs 5-7. Thiopental, with basic pH, reacts with 
acidic muscle relaxants such as suxamethonium, mivacu-
rium, vecuronium and rocuronium, causing precipitation 8. 
Similarly, thiopental causes precipitation with local anesthet-
ics due to pH differences 9. Previous experimental studies 
have shown that thiopental reacting with various drugs may 
form thiopental acid crystals due to precipitation, which 
may cause pulmonary embolism 10. Sugammadex has a pH of 
7.5 and the precipitation reaction with protamine may be 
related to the molecules’ ionic weight 1-5.
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Our study shows that sugammadex reacts with amiodar-
one, dobutamine and protamine under in-vitro conditions, 
causing precipitation. We emphasize that sugammadex 
should not be given intravenously simultaneously with these 
drugs. Future studies will characterize their precipitation 
reaction, which seems to be only the tip of the iceberg. In 
addition, future studies should be focused on investigating 
sugammadex compatibility with other drugs by using Gas 
Chromatography/Mass Spectrometry device. We believe 
the effects of this precipitation on the drugs’ efﬁ cacy and 
circulation warrants further research.
*Volkan Hancı, MD, Assoc. Prof. 
**Hasan Ali Kiraz, MD, Assist. Prof.
**Dilek Ömür, MD, Assist. Prof.
**Serpil Ekin, MD, Assistant Doctor 
**Berna Uyan, MD, Assistant Doctor 
***Bulent Serhan Yurtlu, MD, Assist. Prof. 
Departments of Anaesthesiology and Reanimation,
* Dokuz Eylul  University 
(formerly Canakkale Onsekiz Mart University)
** Canakkale Onsekiz Mart University
*** Dokuz Eylul University (formerly Bulent Ecevit 
University), Turkey
 
References
1.  Naguib M – Sugammadex: another milestone in clinical 
neuromuscular pharmacology. Anesth Analg, 2007;104:575-581. 
2.  Brull SJ, Naguib M – Selective reversal of muscle relaxation in 
general anesthesia: focus on sugammadex. Drug Des Devel Ther, 
2009;3:119-129.
3.  Rex C, Bergner UA, Pühringer FK – Sugammadex: a selective 
relaxant-binding agent providing rapid reversal. Curr Opin 
Anaesthesiol, 2010;23:461-465. 
4.  Zhang M-Q – Drug-speciﬁ c cyclodextrins: the future of rapid 
neuromuscular block reversal? Drugs Future. 2003;28:347-354.
5.  Alston TA – Precipitation of sugammadex by protamine. J Clin 
Anesth, 2011;23:593.
6.  Smith RP, Jones M – Precipitation in Manchester: ketorolac/
cyclizine. Anaesthesia, 2001;56:494-495. 
7.  Ackland G – Physical incompatibility between atracurium and 
intravenous diclofenac. Anaesthesia, 2001;56:294. 
8.  Khan S, Stannard N, Greijn J – Precipitation of thiopental 
with muscle relaxants: a potential hazard. JRSM Short Rep, 
2011;2:58. 
9.  Waters JH, Rizzo VL, Ramanathan S – A re-evaluation of the 
ability of thiopental to identify cerebrospinal ﬂ uid in epidural 
catheter aspirate. J Clin Anesth, 1995;7:224-227.
10.  Taniguchi T, Yamamoto K, Kobayashi T – Precipitate formed by 
thiopentone and vecuronium causes pulmonary embolism. Can 
J Anaesth, 1998;45:347-351.
